ANAB

46.6301.62%
ON

Oleg Nodelman

Independent Chairman of the Board

Mr. Oleg Nodelman, BSFS., is Non-Executive Non-Independent Director of Lakefront Biotherapeutics NV from October 7, 2024. He is Founder and Portfolio Manager of EcoR1 Capital, LLC. He was Managing Director of EcoR1 Capital, LLC. He is Independent Director of AnaptysBio, Inc. from April 08, 2021 and also its Independent Chairman of the Board since August 2026. He is Independent Director of Zymeworks Inc. from February 17, 2025. He is Director of Ajax Therapeutics, Inc. He is Chairman and CEO of Panacea Acquisition Corp. II from April 06, 2021. He was Chief Executive Officer of Panacea Acquisition Corp. II from January 2021 to April 06, 2021. He was Portfolio Manager and Analyst of BVF Partners L.P. He was Director of Kindred Biosciences, Inc. He was employed at Kindred Biosciences, Inc. from November 11, 2013 to December 01, 2014. He was Independent Director of Prothena Corporation plc from December 03, 2019 to December 2024. He was employed at Prothena Corporation plc until December 2024. He was Director of Addex Therapeutics Ltd. He was employed at Addex Therapeutics Ltd from April 28, 2011 to June 27, 2014. He was Director of ReCode Therapeutics, Inc. from October 2021 to 2025. He was employed at ReCode Therapeutics, Inc. until 2025. He was Independent Director of Nuvation Bio Inc. from February 2021 to December 12, 2023. He was employed at Nuvation Bio Inc. until December 12, 2023. He was Director of Scorpion Therapeutics, Inc. He was CEO and Chairman of the Board of Panacea Acquisition Corp. He was Chief Executive Officer of Panacea Acquisition Corp. from April 2020. He was Independent Director of Aktis Oncology, Inc. from February 2021 to May 20, 2026. He was employed at Aktis Oncology, Inc. from February 2021 to May 20, 2026. He was Director of Paratus Sciences Corporation. He has B.S. in Foreign Service, Science and Technology from Georgetown University in 1999.

Positions